TB MAC SEMINAR: WHO methods for estimating levels and trends of rifampicin resistance in tuberculosis patients by Professor Dodd

Thursday, March 9, 10:00am - 11:00am (EST)

Time shown in-04:00 America, New York

Dial-in details:
https://lshtm.zoom.us/j/92322905200?pwd=cW5HeU1HT2ZaMFFYc240ZytZdkNjZz09
Meeting ID: 923 2290 5200 Password: 753122
The WHO produces estimates of the prevalence and incidence of rifampicin-resistant tuberculosis each year in the Global Tuberculosis Report. For the most recent report, a new methodology was developed that generates estimates over time. Here we review the approach to developing these statistical models of rifampicin-resistance prevalence in different patient groups using distinct and sometimes sparse data.
Presenter Bio: Pete Dodd is a modeller and epidemiologist focussed on tuberculosis, originally trained in maths (University of Cambridge) and theoretical physics (Imperial College London), before postdocs in infectious disease modelling at Imperial College London and the London School of Hygiene and Tropical Medicine. Pete is currently based at the School of Health and Related Research at the University of Sheffield, and holds an MRC fellowship centred on the use of mathematical models to better understand TB burden and epidemiology. He is also interested in modelling to interpret and evaluate cluster randomized trials, particularly systematic screening for TB, and interventions to improve detection and management of paediatric TB.

Add to Calendar 2023/03/09 15:00:00 2023/03/09 16:00:00 Europe/London TB MAC SEMINAR: WHO methods for estimating levels and trends of rifampicin resistance in tuberculosis patients by Professor Dodd Dial-in details:
https://lshtm.zoom.us/j/92322905200?pwd=cW5HeU1HT2ZaMFFYc240ZytZdkNjZz09
Meeting ID: 923 2290 5200 Password: 753122
The WHO produces estimates of the prevalence and incidence of rifampicin-resistant tuberculosis each year in the Global Tuberculosis Report. For the most recent report, a new methodology was developed that generates estimates over time. Here we review the approach to developing these statistical models of rifampicin-resistance prevalence in different patient groups using distinct and sometimes sparse data.
Presenter Bio: Pete Dodd is a modeller and epidemiologist focussed on tuberculosis, originally trained in maths (University of Cambridge) and theoretical physics (Imperial College London), before postdocs in infectious disease modelling at Imperial College London and the London School of Hygiene and Tropical Medicine. Pete is currently based at the School of Health and Related Research at the University of Sheffield, and holds an MRC fellowship centred on the use of mathematical models to better understand TB burden and epidemiology. He is also interested in modelling to interpret and evaluate cluster randomized trials, particularly systematic screening for TB, and interventions to improve detection and management of paediatric TB. false MM/DD/YYYY 15 OPAQUE avPISbDQszetdIhaTmDv207145

TB MAC, tbmacofficial@gmail.com

Link: